NTM Info & Research Welcomes Attorney and Rare Disease Advocate, Candace Lerman to Board of Directors Read More ARISE/ENCORE Clinical Trial Program for MAC Lung Disease Read More Learn about visual acuity testing READ MORE NTMir Awards Grant to
Oregon Health & Science University Read More LEARN MORE ABOUT NTM, BRONCHIECTASIS, AND RELEVANT INFORMATION FROM RENOWNED MEDICAL EXPERTS AND RARE DISEASE ADVOCATES. View Videos Join the Phase 3 trial of RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease (CleaR-MAC) Join Clinical Trial European Union approves Arikayce READ MORE inhaled liposomal amikacin We Launched a Companion Website for Bronchiectasis See Website NOW AVAILABLE "INSIGHT" A Patients Perspective Insight into the lung disease caused by nontuberculous mycobacteria (NTM), and empowers the patient to participate in his or her own treatment. AVAILABLE IN VARIOUS LANGUAGES, REQUEST YOUR COPY TODAY. A Physician’s Perspective by Ed Chan, MD DOWNLOAD Airway clearance therapy is an integral part of daily lung care and respiratory hygiene LEARN MORE STAY INFORMED Click here to sign up for the latest news on NTMir SIGN UP NOW
WHO WE ARE
NTMir advances a broad agenda on behalf of people with nontuberculous mycobacterial (NTM) disease, as well as healthcare providers, researchers….